[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361501-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361501-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","metabolite-profiling-and-network-pharmacology-of-persimmon-vinegar-diospyros-kaki-compounds-in-silico-validation-for-non-small-cell-lung-cancer-therapy","Metabolite Profiling and Network Pharmacology of Persimmon Vinegar (Diospyros kaki) Compounds - in silico Validation for Non-Small Cell Lung Cancer Therapy","","Non-small cell lung cancer (NSCLC) is widespread and difficult to treat due to complex molecular mechanisms, drug resistance, and adverse effects from conventional chemotherapy. This study investigates persimmon vinegar compounds produced by spontaneous fermentation, focusing on their enhanced flavonoid/phenolic content and unclear mechanisms in NSCLC. Metabolite profiling, network pharmacology, and molecular docking are integrated to map potential targets and validate binding interactions. Benzoylarginine amine emerges as a lead candidate for inhibiting key pathways involved in tumor progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/metabolite-profiling-and-network-pharmacology-of-persimmon-vinegar-diospyros-kaki-compounds-in-silico-validation-for-non-small-cell-lung-cancer-therapy/361501/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/metabolite-profiling-and-network-pharmacology-of-persimmon-vinegar-diospyros-kaki-compounds-in-silico-validation-for-non-small-cell-lung-cancer-therapy/361501.png","ImageObject",300,407,{"name":42,"@type":43},"pixelkiddo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main goal of this study on persimmon vinegar compounds for NSCLC?","Question",{"text":63,"@type":64},"To map the molecular mechanisms of persimmon vinegar compounds against NSCLC by combining metabolite profiling, network pharmacology, and molecular docking validation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were the persimmon vinegar compounds identified in the methods?",{"text":68,"@type":64},"Compounds were identified using liquid chromatography–tandem mass spectrometry (LC-MS/MS) and then screened for pharmacological properties before network pharmacology and docking analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"Which compound is highlighted as a key candidate and what targets does it bind?",{"text":72,"@type":64},"Benzoylarginine amine is highlighted, showing strong binding affinity to CDK6 (PDB ID: 8I0M) and HRAS (PDB ID: 3K8Y), suggesting potential inhibition of related cancer pathways.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361501,1790387183,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883892,"https://ap-avatar.wpscdn.com/avatar/e00115db34f3e0f11b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1790152879550218658","RESEARCH ARTICLE  \n\n| Editorial Proc | ess: Submission:07/12/2025 Acceptance:02/26/2026 Published:03/06/2026 |\n| --- | --- |\n\nMetabolite Profiling and Network Pharmacology of Persimmon Vinegar (Diospyros kaki) Compounds, with in silico Validation for Non-Small Cell Lung Cancer Therapy  \nRoihatul Mutiah1 *, Ermin Rachmawati2, Imam Taufik3, Alvi Milliana2, Riza Ambar Sari1, Nabila Rahmadani1, Fitriyani Fitriyani1  \nAbstract  \nObjective: Non-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, with complex mechanisms, drug resistance, and significant side effects from conventional chemotherapy, all of which hinder effective treatment. Diospyros kaki (persimmon) vinegar, produced through spontaneous fermentation, has enhanced flavonoid content that may increase its pharmacological activity; however, its molecular mechanisms against NSCLC remain unclear. This is the first study to map the molecular mechanisms of persimmon vinegar compounds against NSCLC by integrating metabolite profiling, network pharmacology, and molecular docking validation. Methods: Compounds were identified using liquid chromatography–tandem mass spectrometry (LC-MS/MS) and screened for pharmacological properties, followed by network pharmacology and molecular docking to explore potential targets against NSCLC. Result: Twentytwo compounds were identified, with three key compounds benzoyl arginine amine, indoline, and exocarpic acid, implicated in theNSCLC pathway (hsa05223). Twenty-seven target genes were associated with this pathway. Benzoylarginine amine exhibited a binding affinity of −86.9707 kcal/mol for CDK6 (PDB ID: 8I0M) and −120.017 kcal/mol for HRAS (PDB ID: 3K8Y), greater than their native ligand, suggesting its potential to inhibit CDK6 activity, block the G1/S phase transition, and suppress cancer cell proliferation via the E2F pathway. Its interaction with HRAS may inhibit the MAPK pathway, which is critical for cancer progression. Conclusion: These findings provide preliminary evidence for the potential of persimmon vinegar compounds as leads for NSCLC drug development, warranting further in vitro and in vivo studies.  \nKeywords: CDK6-HRAS-LCMS/MS-NSCLC-Persimmon  \nAsian Pac J Cancer Prev, 27 (3), 955-965  \nIntroduction  \nNon-small cell lung cancer (NSCLC) is the most prevalent form of lung cancer, comprising about 85% of cases [1]. NSCLC develops from lung epithelial cells and includes subtypes such as adenocarcinoma, squamous cell carcinoma, and large cell carcinoma [2] . Globally, it remains a major cause of cancer-related deaths, with an estimated 1.8 million fatalities annually [3] . Key risk factors, including smoking, air pollution, and radiation exposure, continue to drive its high incidence [4] . These mutations are linked to drug resistance and side effects, posing challenges for treatment [5–7] . Despite progress in targeted and immunotherapies, the five-year survival rate for NSCLC is still low, at only 10–20% . While conventional treatments have evolved, drug resistance  \nand significant adverse effects pose significant challenges inNSCLC management [5–7]. Consequently, developing novel, more effective, and safer therapeutic approaches is urgently needed. Over the past decade, molecular research has unveiled various oncogenic mutations that contribute to NSCLC, including KRAS (20–30%), EGFR (10–40%), andALK translocations (3–5%), which activate pathways such as MAPK and CDK6, which play crucial roles in cell cycle regulation and proliferation [8, 9] . One promising approach to address these challenges is the utilization of natural compounds as adjunctive or alternative therapy. Phytochemicals found in medicinal plants have demonstrated the potential to inhibit cancer cell proliferation, induce apoptosis, and overcome drug resistance [10,11] . However, research on the use of medicinal plants in NSCLC therapy remains limited and  \n1Department of Pharmacy, Faculty of Medical and Health Science, Universitas Islam Ne","cbCaifxXE8Bt6xqE","https://ap.wps.com/l/cbCaifxXE8Bt6xqE","pdf",2155513,11,"English","# Abstract\n# Introduction\n## NSCLC background and therapeutic challenges\n## Natural compounds and persimmon vinegar rationale","[{\"question\":\"What is the main goal of this study on persimmon vinegar compounds for NSCLC?\",\"answer\":\"To map the molecular mechanisms of persimmon vinegar compounds against NSCLC by combining metabolite profiling, network pharmacology, and molecular docking validation.\"},{\"question\":\"How were the persimmon vinegar compounds identified in the methods?\",\"answer\":\"Compounds were identified using liquid chromatography–tandem mass spectrometry (LC-MS/MS) and then screened for pharmacological properties before network pharmacology and docking analysis.\"},{\"question\":\"Which compound is highlighted as a key candidate and what targets does it bind?\",\"answer\":\"Benzoylarginine amine is highlighted, showing strong binding affinity to CDK6 (PDB ID: 8I0M) and HRAS (PDB ID: 3K8Y), suggesting potential inhibition of related cancer pathways.\"}]","Metabolite Profiling and Network Pharmacology of Persimmon Vinegar (Diospyros kaki) Compounds - in silico Validation for Non-Small Cell Lung Cancer Therapy | PDF",1790144619,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/769258789b5d498fe69cb0fe2642cde5.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a58d72f4b5d566650e7a4700a9ff12ab.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38dee969350dc6a83ebc247d5a224334.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b325d1431e8c1983c01374649a8681c6.webp",980,1385]